Correlation Between Milestone Pharmaceuticals and Bluebird Bio
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Bluebird Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Bluebird Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Bluebird bio, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Bluebird Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Bluebird Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Bluebird Bio.
Diversification Opportunities for Milestone Pharmaceuticals and Bluebird Bio
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Milestone and Bluebird is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Bluebird bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluebird bio and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Bluebird Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluebird bio has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Bluebird Bio go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Bluebird Bio
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.7 times more return on investment than Bluebird Bio. However, Milestone Pharmaceuticals is 1.43 times less risky than Bluebird Bio. It trades about 0.29 of its potential returns per unit of risk. Bluebird bio is currently generating about -0.2 per unit of risk. If you would invest 145.00 in Milestone Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 40.00 from holding Milestone Pharmaceuticals or generate 27.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Bluebird bio
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Bluebird bio |
Milestone Pharmaceuticals and Bluebird Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Bluebird Bio
The main advantage of trading using opposite Milestone Pharmaceuticals and Bluebird Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Bluebird Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluebird Bio will offset losses from the drop in Bluebird Bio's long position.The idea behind Milestone Pharmaceuticals and Bluebird bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Bluebird Bio vs. Eliem Therapeutics | Bluebird Bio vs. HCW Biologics | Bluebird Bio vs. Scpharmaceuticals | Bluebird Bio vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |